Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis

被引:153
作者
Humblet-Baron, Stephanie
Sather, Blythe
Anover, Stephanie
Becker-Herman, Shirly
Kasprowicz, Debora J.
Khim, Socheath
Nguyen, Thuc
Hudkins-Loya, Kelly
Alpers, Charles E.
Ziegler, Steve F.
Ochs, Hans
Torgerson, Troy
Campbell, Daniel J.
Rawlings, David J.
机构
[1] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA
[2] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA
[3] Benaroya Res Inst, Seattle, WA USA
[4] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA
[5] Univ Liege, Ctr Cellular & Mol Therapy, B-4000 Liege, Belgium
关键词
D O I
10.1172/JCI29539
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Wiskott-Aldrich syndrome protein (WASP) is essential for optimal T cell activation. Patients with WAS exhibit both immunodeficiency and a marked susceptibility to systemic autoimmunity. We investigated whether alterations in Treg function might explain these paradoxical observations. While WASp-deficient (WASP(-/-)) mice exhibited normal thymic Treg generation, the competitive fitness of peripheral Tregs was severely compromised. The total percentage of forkhead box P3-positive (Foxp3(+)) Tregs among CD4(+)T cells was reduced, and WASP-/- Tregs were rapidly outcompeted by WASp(+) Tregs in vivo. These findings correlated with reduced expression of markers associated with self-antigen-driven peripheral Treg activation and homing to inflamed tissue. Consistent with these findings, WASP-/- Tregs showed a reduced ability to control aberrant T cell activation and autoinimune pathology in Foxp3(-/-) Scurfy (sf) mice. Finally, WASp(+) Tregs exhibited a marked selective advantage in vivo in a WAS patient with a spontaneous revertant mutation, indicating that altered Treg fitness likely explains the autoimmune features in human WAS.
引用
收藏
页码:407 / 418
页数:12
相关论文
共 35 条
[1]   Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome [J].
Ariga, T ;
Kondoh, T ;
Yamaguchi, K ;
Yamada, M ;
Sasaki, S ;
Nelson, DL ;
Ikeda, H ;
Kobayashi, K ;
Moriuchi, H ;
Sakiyama, Y .
JOURNAL OF IMMUNOLOGY, 2001, 166 (08) :5245-5249
[2]   The pathogenesis of autoimmunity in New Zealand mice [J].
Borchers, A ;
Ansari, AA ;
Hsu, T ;
Kono, DH ;
Gershwin, ME .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2000, 29 (06) :385-399
[3]   Mechanisms of WASp-mediated hematologic and immunologic disease [J].
Burns, S ;
Cory, GO ;
Vainchenker, W ;
Thrasher, AJ .
BLOOD, 2004, 104 (12) :3454-3462
[4]   B cells and professional APCs recruit regulatory T cells via CCL4 [J].
Bystry, RS ;
Aluvihare, V ;
Welch, KA ;
Kallikourdis, M ;
Betz, AG .
NATURE IMMUNOLOGY, 2001, 2 (12) :1126-1132
[5]   Autoimmunity in Wiskott-Aldrich syndrome: Risk factors, clinical features, and outcome in a single-center cohort of 55 patients [J].
Dupuis-Girod, S ;
Medioni, J ;
Haddad, E ;
Quartier, P ;
Cavazzana-Calvo, M ;
Le Deist, F ;
Saint Basile, GD ;
Delaunay, J ;
Schwarz, K ;
Casanova, JL ;
Blanche, S ;
Fischer, A .
PEDIATRICS, 2003, 111 (05) :E622-E627
[6]   CD4+CD25+ regulatory T cells inhibit the maturation but not the initiation of an autoantibody response [J].
Fields, ML ;
Hondowicz, BD ;
Metzgar, MH ;
Nish, SA ;
Wharton, GN ;
Picca, CC ;
Caton, AJ ;
Erikson, J .
JOURNAL OF IMMUNOLOGY, 2005, 175 (07) :4255-4264
[7]   Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state [J].
Fisson, S ;
Darrasse-Jèze, G ;
Litvinova, E ;
Septier, F ;
Klatzmann, D ;
Liblau, R ;
Salomon, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (05) :737-746
[8]   A function for interleukin 2 in Foxp3-expressing regulatory T cells [J].
Fontenot, JD ;
Rasmussen, JP ;
Gavin, MA ;
Rudensky, AY .
NATURE IMMUNOLOGY, 2005, 6 (11) :1142-1151
[9]   Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells (Reprinted from vol 4, pg 330-336, 2003) [J].
Fontenot, Jason D. ;
Gavin, Marc A. ;
Rudensky, Alexander Y. .
JOURNAL OF IMMUNOLOGY, 2017, 198 (03) :986-992
[10]   Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells [J].
Huehn, J ;
Siegmund, K ;
Lehmann, JCU ;
Siewert, C ;
Haubold, U ;
Feuerer, M ;
Debes, GF ;
Lauber, J ;
Frey, O ;
Przybylski, GK ;
Niesner, U ;
de la Rosa, M ;
Schmidt, CA ;
Bäuer, R ;
Buer, J ;
Scheffold, A ;
Hamann, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (03) :303-313